Back to CITIGROUP INC CITIGROUP INC

VKTXVKTX

Showing 8 of 11 quarters

Position history for CITIGROUP INCCITIGROUP INC's holdings in VIKING THERAPEUTICS INC

Yes. Citigroup holds 293,126 shares of VKTX (Viking Therapeutics), worth $11.4M, as of its Q2 2026 13F filing. It increased the position by 183,831 shares (+168.2%) from Q1 2026. Citigroup has held VKTX in every 13F on record since Q4 2023, 11 quarterly filings.

Current Value

$11.4M

Current Shares

293,126

Total Value Change

+$3.2M

Total Shares Change

+163,781

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
293,126
+168.2%
$11.4M0.0%$39.01
45
2026-Q1
Increased
109,295
+59.2%
$3.6M0.0%$32.54
38
2025-Q4
Decreased
68,655
-83.4%
$2.4M0.0%$35.18
0
2025-Q3
Decreased
414,603
-52.0%
$10.9M0.0%$26.28
0
2025-Q2
Increased
864,111
+258.8%
$22.9M0.0%$26.50
46
2025-Q1
Increased
240,836
+34.8%
$5.8M0.0%$24.15
35
2024-Q4
Increased
178,647
+38.1%
$7.2M0.0%$40.24
36
2024-Q3
Increased
129,345
+31.5%
$8.2M0.0%$63.31
35

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used